Breakthrough ALS 2013
For over a decade, researchers and scientists have been relying on the ALS Therapy Alliance's expertise and funding to advance their studies of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. 2013 marks the 12th year of our annual Breakthrough ALS fundraising campaign (formerly known as Researching a Cure).
The ALS Therapy Alliance's ongoing grant award process is overseen by the organization's board of award-winning researchers and scientists, as well as corporate executives and individuals who strive to learn more about the neurodegenerative disease, its cause and possible cure.
The organization has raised more than $30 million over the past 11 years thanks to its partnership with CVS/pharmacy.
The ALS Therapy Alliance is designated by the IRS as a not-for-profit 501 (c) (3) organization.
| Points of Interest | |
![]() |
|
![]() |
The ALS Therapy Alliance is fortunate to have a Board of Directors comprised of talented clinicians, scientists and business associates who are committed to the organization’s mission.
Read more: Directors & Staff |
![]() |
Ongoing research is being conducted in the fight against amyotrophic lateral sclerosis (ALS) by our team of clinicians, doctors and scientists at top hospitals and universities. Read more: Current Projects |
![]() |
There are many ways you can help support the research being conducted by the ALS Therapy Alliance to find a cure for amyotrophic lateral sclerosis (ALS), otherwise known as Lou Gehrig's disease. Visit: How Can I Help? |





